(Q53995620)
Statements
Pharmacokinetics of tobramycin in patients with cystic fibrosis. Implications for the dosing interval. (English)
Horrevorts AM
Degener JE
Dzoljic-Danilovic G
Michel MF
Kerrebijn KF
Driessen O
Hermans J
1 August 1985
88
2
260-264